Cargando…
Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer
The mortality rate of liver cancer is gradually increasing worldwide due to the increasing risk factors such as fatty liver, diabetes, and alcoholic cirrhosis. The diagnostic methods of liver cancer include ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), among others...
Autores principales: | Li, Yitong, Zhang, Ruihang, Xu, Zhen, Wang, Zhicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893038/ https://www.ncbi.nlm.nih.gov/pubmed/35250267 http://dx.doi.org/10.2147/IJN.S349426 |
Ejemplares similares
-
Encapsulation of Vitamins Using Nanoliposome: Recent Advances and Perspectives
por: Aman Mohammadi, Masoud, et al.
Publicado: (2023) -
Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan
por: Ko, Andrew H
Publicado: (2016) -
Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy
por: Ye, Haiwei, et al.
Publicado: (2020) -
Advances in Nanoliposomes Production for Ferrous Sulfate Delivery
por: Bochicchio, Sabrina, et al.
Publicado: (2020) -
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
por: Glassman, Danielle C., et al.
Publicado: (2018)